Through controlling the uPAR/Akt/NF-B/IL8 pathway, PLAU can promote esophageal squamous cell carcinoma and change fibroblasts into inflammatory cancer-associated fibroblasts22. The gene discussed is CXCL8; the disease is esophageal squamous cell carcinoma.